Quick fixes will always sound appealing and yet the truth is that with the right exercises and by removing hidden healing blockers, you can usually make faster, safer progress without the risks of surgery (more on that in a moment)
GHK-Cu fits into that picture naturally because it addresses the same biological process from a different angle, restoring the signal instead of forcing the response through physical injury
The complete list of substances being removed from Category 2 is as follows: BPC-157 Cathelicidin LL-37 Dihexa Acetate Emideltide (DSIP) Epitalon GHK-Cu (for injectable routes of administration) KPV Mechano Growth Factor, Pegylated (PEG-MGF) Melanotan II MOTs-C Semax (heptapeptide) Thymosin Beta-4, Fragment (LKKTETQ) (TB-500) Of these, the substances not scheduled for consideration at the upcoming meeting in July (Cathelicidin LL-37, Dihexa Acetate, GHK-Cu (injectable routes of administration), Mechano Growth Factor Pegylated (PEG-MGF), and Melanotan II) are slated for separate PCAC consultation before the end of February 2027
Improvements in cardiometabolic markers, including blood pressure, lipid profiles, and glycaemic control, were also observed
Quality starts with sourcing research-grade peptides from verified suppliers
This is achieved by thoroughly and uniformly mixing sterile material into solvents